24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
LEUCOLIEVA 50MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | LEUCOLIEVA 50MG |
|---|---|
| Composition | Leucovorin Calcium Injection IP 50mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
LEUCOLIEVA 50MG (Leucovorin Calcium Injection IP 50mg) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
LEUCOLIEVA 50 MG (Leucovorin Calcium Injection IP 50 mg) is a prescription medication containing Leucovorin Calcium 50 mg, an active form of folic acid widely used in oncology, chemotherapy support, and specialized medical treatments. Also known as Folinic Acid, Leucovorin plays an important role in reducing the harmful effects of certain chemotherapy medicines while helping improve the effectiveness of selected cancer treatment protocols.
Leucovorin Calcium is different from ordinary folic acid because it does not require metabolic activation by the body. This allows healthy cells to quickly utilize folate, making it especially valuable during cancer treatment. LEUCOLIEVA 50 MG is commonly administered in hospitals, oncology centers, and specialized healthcare facilities under the supervision of qualified healthcare professionals.
One of the primary uses of LEUCOLIEVA 50 MG is Methotrexate Rescue Therapy. High-dose Methotrexate is often used in cancer treatment, but it can also affect healthy cells. Leucovorin helps protect normal tissues from Methotrexate-related toxicity by supplying a biologically active form of folate, thereby reducing side effects and supporting recovery.
In addition to its protective role, Leucovorin is frequently combined with 5-Fluorouracil (5-FU) to enhance its anticancer activity. This combination is commonly used in the treatment of colorectal cancer and other gastrointestinal malignancies. By improving the effectiveness of chemotherapy, Leucovorin contributes to better treatment outcomes in selected cancer patients.
LEUCOLIEVA 50 MG is commonly prescribed for:
Manufactured under strict pharmaceutical quality standards, LEUCOLIEVA 50 MG is designed to provide consistent quality, safety, and therapeutic effectiveness.
Patients receiving Leucovorin therapy may require routine clinical monitoring, laboratory testing, and regular medical assessments to ensure optimal treatment outcomes and patient safety.
Due to its important role in supportive oncology care and chemotherapy management, LEUCOLIEVA 50 MG remains an essential medicine in modern cancer treatment worldwide.
LEUCOLIEVA 50 MG (Leucovorin Calcium Injection IP 50 mg) is used in oncology, chemotherapy support, and selected medical conditions requiring active folate supplementation.
The medicine is widely used to reduce the toxic effects of high-dose Methotrexate treatment.
Leucovorin is commonly administered with 5-Fluorouracil to improve treatment effectiveness.
The medicine may be included in chemotherapy protocols for gastrointestinal malignancies.
It helps protect healthy cells from the adverse effects of certain chemotherapy medicines.
In specific clinical situations, Leucovorin may be prescribed to manage folate deficiency.
The medicine supports multiple cancer treatment protocols involving chemotherapy agents.
Leucovorin contributes to comprehensive oncology treatment strategies.
Leucovorin Calcium belongs to a class of medicines known as Folate Analogues.
LEUCOLIEVA works by:
This dual mechanism makes Leucovorin an important medicine in modern oncology and supportive cancer care.
Like all medicines, LEUCOLIEVA 50 MG may cause side effects in some patients. However, many individuals tolerate the medicine well when administered under medical supervision.
Some patients may experience mild nausea after treatment.
Occasional vomiting may occur in certain individuals.
Weakness and tiredness may develop during therapy.
Pain, redness, or mild irritation at the injection site may occur.
Mild fever may occasionally develop after administration.
Some patients may experience gastrointestinal symptoms.
Mild rash, itching, or skin irritation may occur in rare cases.
Seek immediate medical attention if you experience:
Patients should immediately contact their healthcare provider if serious side effects occur.
The dosage of LEUCOLIEVA 50 MG (Leucovorin Calcium Injection IP 50 mg) should always be determined by a qualified healthcare professional.
Dosage depends on whether the medicine is being used for Methotrexate rescue or chemotherapy enhancement.
The specific treatment regimen influences administration schedules and dosage requirements.
Overall health status and clinical response may affect dosing decisions.
Blood tests and treatment monitoring help guide dosage adjustments.
Previous therapies and individual patient factors may influence treatment planning.
Before receiving treatment, patients should inform their doctor if they have:
Patients should also disclose all prescription medicines, supplements, and herbal products they are currently taking to avoid potential drug interactions.
Pregnant or breastfeeding women should only receive this medicine if specifically recommended by a healthcare professional.
It is primarily used for Methotrexate rescue therapy, chemotherapy support, and in combination with certain anticancer medicines such as 5-Fluorouracil.
Leucovorin Calcium, also known as Folinic Acid, is an active form of folic acid used to reduce chemotherapy toxicity and support cancer treatment protocols.
It is mainly used as supportive therapy and to enhance the effectiveness of specific chemotherapy regimens rather than acting as a standalone cancer treatment.
It helps protect healthy cells from Methotrexate-related toxicity and supports recovery from treatment side effects.
Yes, it is frequently used as part of combination chemotherapy protocols.
Yes, doctors typically recommend laboratory testing and clinical assessments throughout therapy.
Its use depends on the treatment protocol and should always be guided by a qualified healthcare professional.
Yes, this medicine should only be administered by qualified healthcare professionals experienced in oncology, chemotherapy, and supportive cancer care.